Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel HVEM-Fc recombinant protein for lung cancer immunotherapy. | J Exp Clin Cancer Res | 2025 | 39979981 | PubTator, text mining | PubMed |
| Discovery of plasma proteins and metabolites associated with left ventricular cardiac dysfunction in pan-cancer patients. | Cardiooncology | 2025 | 39948601 | PubTator, text mining | PubMed |
| EMZL at various sites: learning from each other. | Blood | 2025 | 39912633 | PubTator, text mining | PubMed |
| Editorial: Oncolytic virotherapy, volume II. | Front Mol Biosci | 2025 | 39906418 | PubTator, text mining | PubMed |
| Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy. | Cancer Immunol Immunother | 2025 | 39904774 | PubTator, text mining | PubMed |
| Genome-Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis. | Arthritis Rheumatol | 2025 | 39887658 | PubTator, text mining | PubMed |
| A rare case of primary testicular follicular lymphoma in a pediatric patient. | J Hematop | 2025 | 39862366 | PubTator, text mining | PubMed |
| Soluble Herpes Virus Entry Mediator and Type II/III Interferons Are Upregulated in Primary Biliary Cholangitis. | Int J Mol Sci | 2025 | 39859319 | PubTator, text mining | PubMed |
| HVEM as a tumor-intrinsic regulator in non-small cell lung cancer: Suppression of metastasis via glycolysis inhibition and modulation of macrophage polarization. | Pharmacol Res | 2025 | 39832683 | PubTator, text mining | PubMed |
| [Expression of BTLA/HVEM axis in hematological and prospects for immune target therapy]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2025 | 39799427 | PubTator, text mining | PubMed |
| The Bidirectional Interplay between T Cell-Based Immunotherapies and the Tumor Microenvironment. | Cancer Immunol Res | 2025 | 39786986 | PubTator, text mining | PubMed |
| Mutational Profiling of Korean Lymphomas and Diffuse Large B-Cell Lymphoma Subtype Classification Using Targeted Panel Sequencing. | Arch Med Res | 2025 | 39765016 | PubTator, text mining | PubMed |
| Causal inference between immune cells and glioblastoma: a bidirectional Mendelian randomization study. | J Cancer | 2025 | 39744577 | PubTator, text mining | PubMed |
| Predicting High-Risk Patients with Lung Adenocarcinoma: The Power of Plasma Cell-Related Genes. | Oncology | 2025 | 39662082 | PubTator, text mining | PubMed |
| Genomic landscape of testicular follicular lymphoma is characterized by frequent 1p36/TNFRSF14 alterations. | Blood Adv | 2025 | 39602674 | PubTator, text mining | PubMed |
| CD34+ and CD34- MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells. | Int J Hematol | 2025 | 39531203 | PubTator, text mining | PubMed |
| Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer Patients. | Adv Sci (Weinh) | 2025 | 39494578 | PubTator, text mining | PubMed |
| Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human Cancers. | J Oncol Res Ther | 2024 | 40083977 | PubTator, text mining | PubMed |
| Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population. | Front Oncol | 2024 | 39882449 | PubTator, text mining | PubMed |
| Adult-Onset Pediatric-Type Follicular Lymphoma of the Parotid Gland. | Cureus | 2024 | 39840177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=9